THYROID CARCINOMA PRIMARY DIFFERENTIATED

Clinical trials for THYROID CARCINOMA PRIMARY DIFFERENTIATED explained in plain language.

Never miss a new study

Get alerted when new THYROID CARCINOMA PRIMARY DIFFERENTIATED trials appear

Sign up with your email to follow new studies for THYROID CARCINOMA PRIMARY DIFFERENTIATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New pill targets multiple cancers in patients out of options

Disease control Not yet recruiting

This is a first-in-human study testing a new oral drug called ACC-1898 in adults with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose and understand how the body processes the drug. Researchers will also look for early …

Matched conditions: THYROID CARCINOMA PRIMARY DIFFERENTIATED

Phase: PHASE1 • Sponsor: AccSalus Biosciences, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

THYROID CARCINOMA PRIMARY DIFFERENTIATED

Get alerted when new THYROID CARCINOMA PRIMARY DIFFERENTIATED trials appear

New pill targets multiple cancers in patients out of options